Seasonal allergic conjunctivitis

Drugs of Today

Volumn 34, Issue 3, 1998, Pages 259-265

  Joss, Jacqueline ^a   Craig, Timothy ^b  

^a UNIVERSITY OF IOWA   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTEMIZOLE; CETIRIZINE; CHLORPHENIRAMINE; CROMOGLYCATE DISODIUM; DEXAMETHASONE; DICLOFENAC; DIPHENHYDRAMINE; FEXOFENADINE; HYDROXYZINE; KETOROLAC; KETOROLAC TROMETAMOL; LEVOCABASTINE; LEVOSTIN; LODOXAMIDE TROMETAMOL; LORATADINE; MEDRYSONE; NAPHAZOLINE; NEDOCROMIL; OLOPATADINE; PREDNISOLONE; PREDNISOLONE ACETATE; PREDNISONE; TERFENADINE; UNCLASSIFIED DRUG; VASOCON A;

ALLERGIC CONJUNCTIVITIS; CATARACT; CLINICAL FEATURE; CONSTIPATION; DIABETES MELLITUS; DROWSINESS; EYE IRRITATION; GLAUCOMA; HUMAN; INCIDENCE; LACRIMATION; LONG QT SYNDROME; OBESITY; REVIEW; SEASONAL VARIATION; TREATMENT PLANNING; VERTIGO; XEROSTOMIA;

EID: 0031982383     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.1998.34.3.485181     Document Type: Review

References (38)

1. Abelson, M.B., George, M.A., Garofalo, C. Differential diagnosis of ocular allergic disorders. Ann Allergy 1993, 70: 95-113.
2. Ponshik, P.C. Allergic conjunctivitis. Int Ophthalmol Clin 1988, 28: 294.
3. Ciprandi, G., Buscaglia, S., Cerqueti, P.M. et al. Drug treatment of allergic conjunctivitis. A review of the evidence. Drugs 1992, 43 (2): 154-76.
4. Friedlaender, M.H. Conjunctivitis of allergic origin: Clinical presentation and differential diagnosis. Surv Ophthalmol 1993, 38 (Suppl.): 104-14.
5. Friedlaender, M.H. Management of ocular allergy. Ann Allergy 1995, 75: 212-24.
6. Friedlaender, M.H. A review of the causes and treatment of bacterial and allergic conjunctivitis. Clin Ther 1995, 17 (5): 800-10.
7. Kelloway, U.S., Wyatt, R.A., Adlis, S.A. Comparison of patient's compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 1994, 154: 1349-52.
8. Abelson, M.B., Schaefer, K. Conjunctivitis of allergic origin. Surv Ophthalmol 1993, 38 (5): 115-32.
9. Abelson, M.B., Allansmith, M.R., Friedlaender, M.H. Effects of topically applied ocular decongestant and antihistamine. Am J Ophthalmol 1980, 90: 254-7.
10. Abelson, A.B., Butrus, S.I. Weston, J.H. et al. Tolerance and absence of rebound vasodilation following topical decongestant use. Ophthalmology 1984, 91: 1364-7.
11. Noble, S., McTavish, D. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis. Drugs 1995, 50 (6): 1032-49.
12. Parys, W., Blockhuys, S., Janssens, M. New trends in the treatment of allergic conjunctivitis. Doc Ophthalmol 1992, 82: 353-60.
13. Pipkorn, U., Bande, M., Hedner, J. et al. A double-blind evaluation of topical levocabastine, a new specific H1 antagonist in patients with allergic conjunctivitis. Allergy 1985, 40: 491-6.
14. Frostad, A.B., Olsen, A.K. A comparison of topical levocabastine and sodium cromoglycate in the treatment of pollen provoked allergic conjunctivitis. Clin Exp Allergy 1993, 23: 406-9.
15. Bende, M., Pipkorn, U. Topical levocabastine, a selective H, antagonist, in seasonal allergic conjunctivitis. Allergy 1987, 42: 512-5.
16. Sohoel, P., Freng, B.A., Kramer, J. et al. Topical levocabastine compared with orally administered terfenadine for the prophylaxis and treatment of seasonal rhinoconjunctivitis. J Allergy Clin Immunol 1993, 92: 73-81.
17. Janssens, M., Blockhuys, S. Tolerability of levocabastine eye drops. Doc Ophthalmol 1993, 84: 111-8.
18. Rombaut, N., Bhatti, J.Z., Curran, S. et al. Effects of topical levocabastine on psychomotor and cognitive function. Ann Allergy 1991, 67: 75-9.
19. Cada, J. (Ed.). Drug Facts and Comparisons. Mosby: St. Louis 1997.
20. Ballas, Z., Blumenthal, M., Tinkelman, D.G. et al. Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol 1993, 38 (Suppl.): 141-48.
21. Woodward, D.F., Nieves, A.I., Joseph, R. et al. Development of animal models for conjunctival and cutaneous itching. Invest Ophthalmol Vis Sci 1995, 36 (Suppl. 1): S10-3.
22. Tinkelman, D.G., Rupp, G., Kaufman, H. et al. Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol 1993, 38 (Suppl.): 133-40.
23. Laibovitz, R.A., Koestart, J., Schaich, L. et al. Safety and efficacy of diclofenac sodium 0.1% ophthalmic solution in acute seasonal allergic conjunctivitis. J Ocular Pharmacol Ther 1995, 11: 361-8.
24. Sitenga, G.L., Img, E.B., Van Pellen, R.G. et al. Asthma caused by topical application of ketorolac. Ophthalmology 1996, 103 (6): 890-2.
25. Sorkin, E.M., Ward, A. Ocular sodium cromoglycate. An overview of its therapeutic efficacy in allergic eye disease. Drugs 1986, 31: 131-48.
26. Juniper, E.F., Guyatt, G.H., Ferrie, P.J. et al. Sodium cromoglycate eye drops: Regular versus "as needed" use in the treatment of seasonal allergic conjunctivitis. J Allergy Clin Immunol 1994, 94: 36-43.
27. Montan, P., Zetterström, O., Eliason, E. et al. Topical sodium cromoglycate (Opticrom) relieves ongoing symptoms of allergic conjunctivitis within 2 minutes. Allergy 1994, 49: 637-40.
28. Leino, M., Montan, P., Nja, F. A double-blind group comparative study of ophthalmic sodium cromoglycate, 2% four times daily and 4% twice daily, in the treatment of seasonal allergic conjunctivitis. Allergy 1994, 49: 147-51.
29. Abelson, M.B., George, M.A., Smith, L.M. Evaluation of 0.05% levocabastine versus cromolyn sodium in the allergen challenge model. Ophthalmology 1995, 102: 310-6.
30. Davies, B.H., Mullins, J. Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis. Allergy 1993, 48: 519-24.
31. Leino, M., Carlson, C., Kilkku, O. et al. The effect of sodium cromoglycate eyedrops compared to the effect of terfenadine for acute symptoms of seasonal allergic conjunctivitis. Acta Ophthalmol 1992, 70: 341-45.
32. Calogne, M., Montero, J.A., Herreras, M. et al. Efficacy of nedocromil sodium and cromolyn sodium in an experimental model of ocular allergy. Ann Allergy Asthma Immunol 1996, 77: 124-30.
33. Hammann, G., Kammerer, L., Gerber, M. et al. Comparison of effects of levocabastine and nedocromil sodium on the early response in a conjunctival provocation test with allergen. J Allergy Clin Immunol 1996, 98: 1045-50.
34. Alexander, M. Comparative therapeutic studies with Tilavist. Allergy 1995, 50 (Suppl. 21): 23-9.
35. Leonardi, A.A., Smith, L.M., Fregona, I.A. et al. Tear histamine and histaminase during the early and late phases of allergic reaction and the effects of lodoxamide. Eur J Ophthalmol 1996, 6: 106-12.
36. Cerqueti, P.M., Ricca, V., Tosca, M.A. et al. Lodoxamide treatment of allergic conjunctivitis. Int Arch Allergy Appl Immunol 1994, 105: 185-9.
37. Andri, L., Senna, G., Betteli, C. et al. Local nasal immunotherapy with extract in powder form is effective and safe in grass pollen rhinitis: A double blind study. J Allergy Clin Immunol 1996, 97: 34-41.
38. Hedlin, G., Heilborn, H., Lilja, G. et al. Long term follow-up of patients treated with a three year course of cat or dog immunotherapy. J Allergy Clin Immunol 1995, 96: 879-85.